Royal Bank of Canada’s SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.08M Sell
26,624
-754
-3% -$30.6K ﹤0.01% 3520
2025
Q1
$1.2M Sell
27,378
-23,726
-46% -$1.04M ﹤0.01% 3024
2024
Q4
$2.2M Buy
51,104
+26,173
+105% +$1.13M ﹤0.01% 2601
2024
Q3
$1.11M Sell
24,931
-12,937
-34% -$574K ﹤0.01% 3081
2024
Q2
$1.51M Buy
37,868
+8,456
+29% +$336K ﹤0.01% 2815
2024
Q1
$1.27M Buy
29,412
+3,003
+11% +$130K ﹤0.01% 2907
2023
Q4
$1.1M Sell
26,409
-22,954
-47% -$955K ﹤0.01% 3117
2023
Q3
$1.96M Buy
49,363
+13,038
+36% +$518K ﹤0.01% 2487
2023
Q2
$1.49M Sell
36,325
-11,950
-25% -$490K ﹤0.01% 2712
2023
Q1
$1.98M Buy
48,275
+10,259
+27% +$421K ﹤0.01% 2508
2022
Q4
$1.56M Sell
38,016
-6,653
-15% -$272K ﹤0.01% 2749
2022
Q3
$1.79M Buy
44,669
+1,887
+4% +$75.8K ﹤0.01% 2558
2022
Q2
$1.8M Sell
42,782
-19,097
-31% -$802K ﹤0.01% 2632
2022
Q1
$2.8M Sell
61,879
-1,419
-2% -$64.3K ﹤0.01% 2397
2021
Q4
$2.92M Buy
63,298
+12,953
+26% +$598K ﹤0.01% 2429
2021
Q3
$2.39M Buy
50,345
+25,080
+99% +$1.19M ﹤0.01% 2546
2021
Q2
$1.31M Sell
25,265
-6,539
-21% -$339K ﹤0.01% 3051
2021
Q1
$1.6M Buy
31,804
+6,052
+24% +$305K ﹤0.01% 2800
2020
Q4
$1.34M Sell
25,752
-10,688
-29% -$557K ﹤0.01% 2825
2020
Q3
$1.58M Buy
36,440
+8,195
+29% +$356K ﹤0.01% 2508
2020
Q2
$1.21M Sell
28,245
-2,176
-7% -$93.5K ﹤0.01% 2640
2020
Q1
$1.1M Buy
30,421
+12,001
+65% +$433K ﹤0.01% 2580
2019
Q4
$841K Sell
18,420
-14,271
-44% -$652K ﹤0.01% 3052
2019
Q3
$1.16M Buy
32,691
+3,240
+11% +$115K ﹤0.01% 2740
2019
Q2
$1.17M Buy
29,451
+11,830
+67% +$472K ﹤0.01% 2710
2019
Q1
$732K Sell
17,621
-39,862
-69% -$1.66M ﹤0.01% 2950
2018
Q4
$2.11M Buy
57,483
+36,466
+174% +$1.34M ﹤0.01% 2144
2018
Q3
$1.02M Buy
21,017
+3,874
+23% +$188K ﹤0.01% 2827
2018
Q2
$738K Sell
17,143
-614
-3% -$26.4K ﹤0.01% 2948
2018
Q1
$742K Sell
17,757
-22,334
-56% -$933K ﹤0.01% 2854
2017
Q4
$1.74M Buy
40,091
+9,341
+30% +$406K ﹤0.01% 2296
2017
Q3
$1.31M Buy
30,750
+10,869
+55% +$463K ﹤0.01% 2453
2017
Q2
$856K Sell
19,881
-20,211
-50% -$870K ﹤0.01% 2652
2017
Q1
$1.68M Sell
40,092
-9,738
-20% -$407K ﹤0.01% 2210
2016
Q4
$1.95M Buy
49,830
+42,059
+541% +$1.64M ﹤0.01% 2085
2016
Q3
$344K Buy
7,771
+1,353
+21% +$59.9K ﹤0.01% 3343
2016
Q2
$268K Sell
6,418
-3,597
-36% -$150K ﹤0.01% 3543
2016
Q1
$403K Buy
10,015
+2,704
+37% +$109K ﹤0.01% 3227
2015
Q4
$375K Sell
7,311
-7,358
-50% -$377K ﹤0.01% 3380
2015
Q3
$688K Sell
14,669
-21,999
-60% -$1.03M ﹤0.01% 2693
2015
Q2
$2.29M Sell
36,668
-24,600
-40% -$1.53M ﹤0.01% 1899
2015
Q1
$3.78M Buy
61,268
+7,784
+15% +$481K ﹤0.01% 1513
2014
Q4
$2.89M Buy
53,484
+6,488
+14% +$350K ﹤0.01% 1687
2014
Q3
$2.49M Sell
46,996
-3,962
-8% -$210K ﹤0.01% 1780
2014
Q2
$2.65M Sell
50,958
-7,008
-12% -$364K ﹤0.01% 1761
2014
Q1
$2.71M Sell
57,966
-7,712
-12% -$361K ﹤0.01% 1699
2013
Q4
$2.89M Sell
65,678
-28,938
-31% -$1.27M ﹤0.01% 1620
2013
Q3
$3.64M Buy
94,616
+78,450
+485% +$3.02M ﹤0.01% 1458
2013
Q2
$570K Buy
+16,166
New +$570K ﹤0.01% 2535